Tanya Herzog, DVM, DACLAM
Tanya Herzog, director of the comparative medicine core at Houston Methodist, oversees a team that conducts studies in both large and small preclinical models in the pursuit of scientific excellence for the benefit of public health. Herzog has more than 15 years of experience directing all aspects of Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC)-accredited animal programs and working with investigators to successfully navigate novel translational research projects from inception through efficacy trials and GLP-compliant safety assessments.
John Cooke, chair of the Department of Cardiovascular Sciences at the Houston Methodist Research Institute and the director of the Center for Cardiovascular Regeneration in the DeBakey Heart & Vascular Center, has published over 500 papers, reviews, book chapters and patents in the arena of vascular medicine and biology with over 20,000 citations. His translational research focuses on vascular regeneration, and is funded by grants from the NIH, American Heart Association and industry.
William (Billy) Cohn, MD
Dr. William E. “Billy” Cohn is the Vice President for Johnson & Johnson Medical Devices Companies and the Executive Director of the new Center for Device Innovation at the Texas Medical Center in Houston. Dr. Cohn has a passion for medical device development and has more than 90 US patents granted or pending for his medical innovations that have provided the core technology for six venture-backed medical start-ups.
Stephen Igo is director of the Houston Methodist Entrepreneurial Institute at the DeBakey Heart & Vascular Center. The Entrepreneurial Institute prioritizes technology and competence transfer, fostering knowledge sharing and innovation across industries to accelerate life-saving heart and vascular therapies and technological discoveries.
Edward Jones, chief executive officer at Houston Methodist Research Institute, oversees academic administrative functions, including governance, communications, financial services, grants and contracts, regulatory oversight and research protections. He also is responsible for the Academic Office for Clinical Trials, which provides leadership for clinical trial operations and for regulatory and coordinator support.
Alan Lumsden, the Walter W. Fondren III Distinguished Endowed Chair, DeBakey Heart & Vascular Center and chair of the Department of Cardiovascular Surgery at Houston Methodist, is a leader in the field of endovascular surgery. He has clinical and research expertise in stent graft treatment of thoracic and abdominal aortic aneurysms, stenting and endarterectomy in carotid arterial disease, renovascular hypertension, aortoiliac occlusive disease, mesenteric vascular and minimally invasive therapy in venous disease.
Robert Rostomily, the John S. “Steve” Dunn, Jr. and Dagmar Dunn Pickens Gipe Chair in Brain Tumor Research, Department of Neurosurgery at Houston Methodist. His Glioblastoma Research Lab is involved in diverse projects that address basic and translational biology of brain cancers, with a primary focus on glioblastoma (GBM).